Quick Answer
ORTHOPEDIATRICS CORP reported Operating Income Loss of -$39.24 million for the year ending 2025.
- ORTHOPEDIATRICS CORP showed a decrease of -12.1% in Operating Income Loss from 2024 to 2025.
- This data is from ORTHOPEDIATRICS CORP's annual report (Form 10-K), filed with the SEC on March 4, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2016: -$1.49 million | Q2 2016: -$865.0 thousand | Q3 2016: -$524.0 thousand | Q4 2016: -$3.25 million | Q1 2017: -$837.0 thousand | Q2 2017: -$677.0 thousand | Q3 2017: -$754.0 thousand | Q4 2017: -$4.20 million | Q1 2018: -$4.40 million | Q2 2018: -$2.12 million | Q3 2018: -$1.17 million | Q4 2018: -$1.87 million | Q1 2019: -$2.72 million | Q2 2019: -$1.79 million | Q3 2019: -$1.54 million | Q4 2019: -$3.03 million | Q1 2020: -$4.50 million | Q2 2020: -$7.02 million | Q3 2020: -$2.50 million | Q4 2020: -$12.74 million | Q1 2021: -$5.97 million | Q2 2021: -$2.85 million | Q3 2021: -$3.64 million | Q4 2021: -$5.56 million | Q1 2022: -$6.39 million | Q2 2022: -$3.74 million | Q3 2022: -$6.96 million | Q1 2023: -$8.59 million | Q2 2023: -$5.59 million | Q3 2023: -$4.51 million | Q1 2024: -$9.72 million | Q2 2024: -$5.67 million | Q3 2024: -$5.57 million | Q1 2025: -$10.98 million | Q2 2025: -$10.66 million | Q3 2025: -$9.43 million.
- Over the full 11 years of available data (2015 to 2025), ORTHOPEDIATRICS CORP's Operating Income Loss has declined by 495.2%.
- Historical annual values: Fiscal year 2025: -$39.24 million | Fiscal year 2024: -$35.01 million | Fiscal year 2023: -$26.75 million | Fiscal year 2022: -$25.40 million | Fiscal year 2021: -$18.02 million | Fiscal year 2020: -$26.76 million | Fiscal year 2019: -$9.08 million | Fiscal year 2018: -$9.55 million | Fiscal year 2017: -$6.47 million | Fiscal year 2016: -$6.13 million | Fiscal year 2015: -$6.59 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: